Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,920 | 713 | 41 | 279 | 286 |
| Gross Profit | 3,920 | 713 | 41 | 279 | 286 |
| Operating Expenses | 31,724 | 28,795 | 26,302 | 23,540 | 23,416 |
| Operating Income | -27,804 | -28,082 | -26,261 | -23,261 | -23,130 |
| Interest Expense | 0 | 426 | 499 | 495 | 486 |
| Other Income | 890 | -635 | 680 | 645 | 630 |
| Pre-tax Income | -26,914 | -29,143 | -26,080 | -23,111 | -22,986 |
| Net Income Continuous | -26,914 | -29,143 | -26,080 | -23,111 | -22,986 |
| Net Income | $-26,914 | $-29,143 | $-26,080 | $-23,111 | $-22,986 |
| EPS Basic Total Ops | -0.65 | -0.77 | -0.71 | -0.63 | -0.62 |
| EPS Basic Continuous Ops | -0.65 | -0.77 | -0.71 | -0.63 | -0.62 |
| EPS Diluted Total Ops | -0.65 | -0.77 | -0.71 | -0.63 | -0.62 |
| EPS Diluted Continuous Ops | -0.65 | -0.77 | -0.71 | -0.63 | -0.62 |
| EBITDA(a) | $-26,955 | $-27,175 | $-25,300 | $-22,482 | $-22,371 |